These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17506122)
1. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. Cooper LT; Mensah GA; Baddour LM; Dunbar SB; Kaplan EL; Wilson WR; Shah PK Circulation; 2007 Mar; 115(12):1681-9. PubMed ID: 17506122 [No Abstract] [Full Text] [Related]
2. ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. Cooper LT; Mensah GA; Baddour LM; Dunbar SB; Kaplan EL; Wilson WR; Shah PK J Am Coll Cardiol; 2007 Mar; 49(12):1398-406. PubMed ID: 17394981 [No Abstract] [Full Text] [Related]
3. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force I: direct cardiovascular implications of emerging infectious diseases and biological terrorism threats. Baddour LM; Zheng ZJ; Labarthe DR; O'Connor S Circulation; 2007 Mar; 115(12):1663-72. PubMed ID: 17506120 [No Abstract] [Full Text] [Related]
4. ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task force I: direct cardiovascular implications of emerging infectious diseases and biological terrorism threats. Baddour LM; Zheng ZJ; Labarthe DR; O'Connor S J Am Coll Cardiol; 2007 Mar; 49(12):1380-9. PubMed ID: 17394979 [No Abstract] [Full Text] [Related]
5. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs. Madjid M; Luepker RV; Greenland KJ; Taubert KA; Roy MJ; Robertson RM Circulation; 2007 Mar; 115(12):1690-5. PubMed ID: 17506124 [No Abstract] [Full Text] [Related]
6. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs. Madjid M; Luepker RV; Greenlund KJ; Taubert KA; Roy MJ; Robertson RM J Am Coll Cardiol; 2007 Mar; 49(12):1407-12. PubMed ID: 17394982 [No Abstract] [Full Text] [Related]
7. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Mensah GA; Grant AO; Pepine CJ J Am Coll Cardiol; 2007 Mar; 49(12):1376-9. PubMed ID: 17394978 [No Abstract] [Full Text] [Related]
8. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Mensah GA; Grant AO; Pepine CJ Circulation; 2007 Mar; 115(12):1659-62. PubMed ID: 17372164 [No Abstract] [Full Text] [Related]
9. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. Omato J; Muller JE; Froelicher ES; Kloner RA Circulation; 2007 Mar; 115(12):1672-80. PubMed ID: 17506121 [No Abstract] [Full Text] [Related]
10. ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. Ornato JP; Muller JE; Froelicher ES; Kloner RA J Am Coll Cardiol; 2007 Mar; 49(12):1389-97. PubMed ID: 17394980 [No Abstract] [Full Text] [Related]
11. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Mensah GA; Grant AO; Pepine CJ; Baddour LM; Cooper LT; Dunbar SB; Froelicher ES; Greenlund KJ; Kaplan EL; Kloner RA; Labarthe DR; Luepker RV; Madjid M; Muller JE; O'Connor S; Ornato JP; Robertson RM; Roy MJ; Shah PK; Taubert KA; Wilson WR; Zheng ZJ; Harrington RA; Abrams J; Anderson JL; Bates ER; Eisenberg MJ; Grines CL; Hlatky MA; Lichtenberg RC; Lindner JR; Pohost GM; Schofield RS; Shubrooks SJ; Stein JH; Tracy CM; Vogel RA; Wesley DJ J Am Coll Cardiol; 2007 Mar; 49(12):1373-412. PubMed ID: 17394977 [No Abstract] [Full Text] [Related]
12. ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Mensah GA; Grant AO; Pepine CJ; Baddour LM; Cooper LT; Dunbar SB; Froelicher ES; Greenlund KJ; Kaplan EL; Kloner RA; Labarthe DR; Luepker RV; Madjid M; Muller JE; O'Connor S; Ornato JP; Robertson RM; Roy MJ; Shah PK; Taubert KA; Wilson WR; Zheng ZJ; Harrington RA; Abrams J; Anderson JL; Bates ER; Eisenberg MJ; Grines CL; Hlatky MA; Lichtenberg RC; Lindner JR; Pohost GM; Schofield RS; Shubrooks SJ; Stein JH; Tracy CM; Vogel RA; Wesley DJ Circulation; 2007 Mar; 115(12):1656-95. PubMed ID: 17372165 [No Abstract] [Full Text] [Related]
13. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Bonow RO; Douglas PS; Buxton AE; Cohen DJ; Curtis JP; Delong E; Drozda JP; Ferguson TB; Heidenreich PA; Hendel RC; Masoudi FA; Peterson ED; Taylor AJ J Am Coll Cardiol; 2011 Sep; 58(14):1517-38. PubMed ID: 21880456 [TBL] [Abstract][Full Text] [Related]
14. [Urgent issues in counteraction with the biological danger]. Onishchenko GG; Drozdov IG Vestn Ross Akad Med Nauk; 2004; (5):14-20. PubMed ID: 15320544 [No Abstract] [Full Text] [Related]
15. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Bonow RO; Douglas PS; Buxton AE; Cohen DJ; Curtis JP; Delong E; Drozda JP; Ferguson TB; Heidenreich PA; Hendel RC; Masoudi FA; Peterson ED; Taylor AJ; ; Circulation; 2011 Sep; 124(13):1483-502. PubMed ID: 21875906 [TBL] [Abstract][Full Text] [Related]
16. ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. Francis GS; Greenberg BH; Hsu DT; Jaski BE; Jessup M; LeWinter MM; Pagani FD; Piña IL; Semigran MJ; Walsh MN; Wiener DH; Yancy CW; J Am Coll Cardiol; 2010 Jul; 56(5):424-53. PubMed ID: 20650365 [No Abstract] [Full Text] [Related]
17. Early detection and surveillance for biopreparedness and emerging infectious diseases. Veenema TG; Tõke J Online J Issues Nurs; 2006 Jan; 11(1):3. PubMed ID: 16629504 [TBL] [Abstract][Full Text] [Related]
18. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease. Rotz LD; Hughes JM Nat Med; 2004 Dec; 10(12 Suppl):S130-6. PubMed ID: 15577931 [TBL] [Abstract][Full Text] [Related]
19. Task force 1: The ACCF and AHA codes of conduct in human subjects research. Alpert JS; Shine KI; Adams RJ; Antman EM; Kavey RE; Friedman L; Frye RL; Harrington RA; Korn D; Merz JF; Ofili E J Am Coll Cardiol; 2004 Oct; 44(8):1724-8. PubMed ID: 15489115 [No Abstract] [Full Text] [Related]
20. The European Centre for Infectious Diseases: an adequate response to the challenges of bioterrorism and major natural infectious threats. Tibayrenc M; Mas-Coma S; Piffaretti JC; Struelens M Infect Genet Evol; 2002 May; 1(3):179-81. PubMed ID: 12798013 [No Abstract] [Full Text] [Related] [Next] [New Search]